|
Friday, February 6th |
| Afternoon |
S1. Novel
technologies in arrhythmia Part 1 |
|
| Cryoablation
for all |
|
| Haemodynamic
monitoring |
|
| How
smart can devices get? |
|
| S2.
Novel technologies in arrhythmia Part 2 |
|
| Leadless
ICD update |
|
| Implantable
loop recorders |
|
| Do we need device registries if we already
have clinical trials? |
|
|
|
|
Saturday,
February 7th |
|
EP Stream |
Device Stream |
| Morning |
S3. Challenges
of SVT |
Participants in all-day device sessions will be
divided into small group interactive workshops to review advanced programming
and trouble-shooting topics related to pacemakers, CRT and ICDs |
| Multifocal
atrial tachycardia |
| Pacing
maneuvers new and old |
| Cryoablation
of accessory pathways |
| S4.
Pharmacology and pathophysiology of arrhythmias Part 1 |
| Amiodarone:
40 years of experience |
| Pharmacology
of VT/VF in Brugada syndrome |
| Polypharmacology
for atrial arrhythmia |
| S5.
Pharmacology and pathophysiology of arrhythmias Part 2 |
| Short
QT |
| Drug
induced LQT: real threat? |
| How to
find and identify LQT patients |
| Evening |
Interactive
Session |
Interactive
Session |
| S6.
Imaging guidance in electrophysiology |
More
device sessions |
| Live
MRI |
| Live
Ultrasound |
| Pre-intervention
imaging and integrated imaging |
| Imaging
for CRT |
|
|
|
|
Sunday,
February 8th |
| Morning |
S7. Ablative
strategies in atrial fibrillation |
|
| Ablation patient
selection and strategy |
|
| Cryoablation for atrial
fibrillation |
|
| Post-ablation arrhythmia |
|
| Single catheter ablation |
|
| S8.
Risk assessment in cardiac electrophysiology |
|
| Case 1 |
|
| Case 2 |
|
| S9.
Pharmacology and pathophysiology of arrhythmias Part 3 |
|
| Early repolarization |
|
| Novel Na channel
blockers |
|
| Inappropriate sinus
tachycardia |
|